| The
European Multiple System Atrophy Study Group (EMSA-SG) was founded in
January 1999. It represents a consortium of scientific investigators from
academic and research centres in Europe and Israel who are committed to
clinical trial activity and other research studies aimed at improving the
treatment of MSA. To this end, EMSA-SG aims to advance knowledge about the
aetiology and pathogenesis of MSA. Furthermore, EMSA-SG will work with government
and industry sponsors to develop and implement novel therapeutic interventions
in MSA. EMSA-SG is committed to the principles of open and full scientific
communication. EMSA-SG is also interested in educating professionals and
the public by providing scientific and medical information about MSA. EMSA-SG
intends to pursue these objectives in close cooperation with the North American
MSA Study Group (NAMSA-SG). |
|
